Morningside Group Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 22
Professionals
  • Investments
  • 268
  • Portfolio
  • 131
  • Exits
  • 74
Exits

Morningside Group General Information

Description

Morningside Group is an investment firm that was founded in 1986 and is based in Hong Kong, Hong Kong. The firm makes private equity and venture capital investments in the information technology, life sciences and clean technology sectors. It also participates in philanthropic activities to enable education, support science and fund medical research.

Contact Information

Year Founded
1986
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
  • 22nd Floor, Hang Lung Centre
  • 2-20 Paterson Street, Causeway Bay30
  • Hong Kong
  • Hong Kong

Morningside Group Investments (268)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Gracell 28-Oct-2020 Later Stage VC 00000 Biotechnology Clinical Trials - Phase 1
0000000 0000000000 21-Oct-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
0000 0000000000000 01-Oct-2020 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
0000000 0000000000 23-Sep-2020 00000 00000 0000 Drug Discovery Product Development 00 00000 00
0000 0000000000 23-Sep-2020 00000 00000 000.00 Laboratory Services (Healthcare) Generating Revenue/Not Profitable
000000 0000000000 21-Sep-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 00000 00000 00
000000000000 25-Aug-2020 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue
000 12-Aug-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 0000 0000
Vesigen Therapeutics 25-Jul-2020 Early Stage VC 000.00 Drug Delivery Startup 000000 0000 00.0
BaseBit.ai 06-Jul-2020 Early Stage VC Database Software Generating Revenue
You’re viewing 10 of 268 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Morningside Group Exits (74)

Company Name Exit Date Exit Type Exit Size
Atea Pharmaceuticals 30-Oct-2020 IPO 00000
0000 0000000 03-Mar-2020 000 00 00000000
0000000000 0000 00 25-Nov-2019 000000000000000000
00000000000 000000 25-Oct-2019 000000000000000000 00000
000000000 00000000 03-Oct-2019 000 0000
0000000000 00 13-May-2019 0000000000
0000000 18-Apr-2019 000 00 00000000
000 (00000000000 0 01-Apr-2019 000 00 00000000
Apellis 06-Mar-2019 Public Investment 2nd Offering 00000
Twelve Springs 01-Mar-2019 Out of Business
You’re viewing 10 of 74 exits. Get the full list »

Morningside Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Morningside Group Team (29)

Name Title Deals Funds Boards Office
Ka Chang Managing Director 0 Hong Kong, Hong Kong
Lu Huang MD Managing Director 0 0 Shanghai, China
Tony Yeung Managing Director 0 Beijing, China
Cheng Yu Partner 0 0 0 Newton, MA
Haiyan Wang Investment Professional Shanghai, China
You’re viewing 5 of 29 team members. Get the full list »

Morningside Group Co-Investors (312)

Name With Exits Lead Partner Series Industry
Cormorant Asset Management 4 0 Series chart Industry bar
Sinovation Ventures 0 0 0 Series chart Industry bar
Tamarisc Ventures 0 0 0 Series chart Industry bar
Bessemer Venture Partners 0 0 Series chart Industry bar
Pappas Capital 0 0 Series chart Industry bar
You’re viewing 5 of 312 co-investors. Get the full list »